Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profiling by RNA-seq of SW480 and HCT116 cells after TGM2 knockdown

ABSTRACT: Molecular characterization of TGM2-knockdown cells reveals p53 as a central mediator of TGM2-signaling

ORGANISM(S): Homo sapiens

PROVIDER: GSE130482 | GEO | 2021/07/14

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression profiling by RNA-seq of SW480 and HCT116 cells after TGM2 knockdown

Project description:Gene expression profiling by RNA-seq of SW480 and HCT116 cells after TGM2 knockdown

| PRJNA540435 | ENA

TGM2-Mediated Histone Transglutamination is Dictated by Steric Accessibility

Project description:Histone monoaminylation is a new class of chromatin post-translational modification whereby glutamines are transamidated by tissue transglutaminase 2 (TGM2). Initial studies of these marks have identified serotonylation and dopaminylation on H3Q5, suggesting the modification is a marker of active chromatin. However, little work has been conducted to understand the regulation of TGM2-mediated monoaminylation of chromatin. Here, we employed a highly sensitive TGM2 assay using the small molecule biotin-cadaverine as an acyl-acceptor substrate. In doing so, we discovered that, in addition to H3Q5, H3Q19 and H2A.ZQ123 and Q124 are glutaminyl substrates for TGM2 in vitro. Modification of these residues occurs in a sequence independent manner, with the primary determining factor for substrate selectivity being steric accessibility. We demonstrated that moving substrate glutamines near the histone fold domain turns them into non-substrates. Furthermore, we found that steric accessibility of glutamines appears to be controlled by higher order chromatin structures. Using nucleosome arrays as substrates, we successfully showed that formation of chromatin fibers in vitro reduces levels of monoaminylation. We then successfully extended these findings to a cell based system, showing that TGM2 is not enriched in heterochromatin and that H3Q5 serotonylation and H3K9me3 are mutually exclusive marks. In total, our results strongly suggest that TGM2, and monoaminylation, are excluded from heterochromatin based on steric accessibility

2022-10-05 | GSE198978 | GEO

TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway [Cut & Tag]

Project description:Hepatocellular carcinoma (HCC) is a formidable malignancy with limited effective therapeutic avenues. This study was designed to investigate the role of transglutaminase 2 (TGM2) in promoting HCC progression and assess its potential as a target for therapeutic intervention in HCC treatment.TMG2 expression was positively related to a higher AFP level, poor differentiation, and a later BCLC stage. Tgm2 deficiency or H3Q5ser inhibition notably restrained HCC progression. Mechanism research revealed that TGM2-mediated H3Q5ser modifications promote HCC progression via MYC pathway signaling. Furthermore, transcriptional intermediary factor 1 beta (TIF1-β/TRIM28) mediated the recruitment of TGM2 by MYC to facilitate H3Q5ser modifications on MYC targets. Finally, targeting the TGM2 transglutaminase activity significantly suppressed HCC progression in preclinical models.

2024-12-16 | GSE283278 | GEO

TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway [RNA-Seq]

2024-12-16 | GSE283279 | GEO

RNA-seq of PANC-1 cells after TGM2 KD

Project description:The PANC-1 cells were maintained on DMEM supplemented with 10% FBS, 1% penicillin-streptomycin. RNA-seq of PANC-1 cells after TGM2 KD.

2025-01-01 | E-MTAB-14474 | biostudies-arrayexpress

Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma

Project description:Melanoma is the deadliest form of skin cancer. MAPK-targeted therapies (MAPKi) and immune checkpoint inhibitors (ICI) have shown clinical benefit but are limited by resistance mechanisms that remain poorly defined. MNK1/2 inhibitors (MNKi) have shown promising effects in pre-clinical tumor models, particularly in melanoma. Herein, we find that bromodomain and extra-terminal domain protein inhibitors (BETi) in combination with MNKi reduce the proliferation of melanoma cells, including cells with acquired MAPKi resistance. Transcriptomic and proteomic analyses reveal that tissue transglutaminase TGM2 and inhibition of FAK activation are downstream effectors of this combination. We further demonstrate that TGM2 is overexpressed in MAPKi-resistant melanoma cells and that silencing TGM2 inhibits the proliferation of therapy-resistant melanoma cells. Our results introduce TGM2 as a new vulnerability in therapy-resistant melanoma development and suggest that a combination of MNKi and BETi may address the clinical need for novel therapies targeting unresponsive and drug-resistant melanoma.

2024-06-30 | GSE260507 | GEO

Combined inhibition of MNK signaling and BET proteins reveals TGM2 as a novel vulnerability in melanoma

2024-10-01 | PXD044698 | Pride

TGM2-Mediated Histone Transglutamination is Dictated by Steric Accessibility

Project description:TGM2-Mediated Histone Transglutamination is Dictated by Steric Accessibility

| PRJNA817606 | ENA

RNA-seq of PANC-1 cells after TGM2 KD

Project description:RNA-seq of PANC-1 cells after TGM2 KD

| PRJEB80465 | ENA

TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway

Project description:TGM2 IP-MS was performed in MHCC-97H cells to screen the interactors of TGM2. 5-PT pulldown-MS was perfromed in MHCC-97H cells to identify proteins modified by serotonylation.

2024-12-06 | PXD058674 |

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data